Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx
Clinical trial NCT00071890 · COMPLETED
Trial details
- NCT number
- NCT00071890
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2007-12-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.